The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, ... 2010 spiriva-handihaler-spiriva-respimat-tiotropium-343446 ...

GSP 304 is a tiotropium bromide solution that Glenmark delivers as a mist. The FDA has already approved inhaled powder and spray versions of it. The powder version is Spiriva HandiHaler and the spray ...

Tiotropium DPI is recognised for its ability to help patients with respiratory diseases by improving lung function and quality of life. This partnership supports Lupin’s efforts to widen its reach in ...

Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China's Sino Universal Pharmaceuticals for the commercialisation of Tiotropium dry powder inhaler in the Chinese ...

Lupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler treats Chronic Obstructive Pulmonary Disease. Sino Universal ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP), for the commercialisation of Tiotropium Dry Powder Inhaler (DPI), 18 ...

Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. This partnership will enable Lupin to expand its footprint ...

Lupin has signed a licensing deal with China’s Sino Universal Pharmaceuticals to bring its Tiotropium inhaler to the Chinese market. The product, used for treating COPD, will be manufactured by ...

The company has entered into a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for the commercialization of Tiotropium Dry Powder Inhaler (DPI), 18 mcg/capsule.

Tiotropium is the first long-acting anticholinergic drug that has been developed in the early 1990s and approved for the management of ... administered through the Respimat® inhaler for 8 weeks.

NEW DELHI, June 16: Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China’s Sino Universal Pharmaceuticals for the commercialisation of Tiotropium dry powder ...

Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist ...